UnitedRx, the Midwest’s largest full-service, independent long-term care pharmacy, is proud to announce its support for the recent drop in insulin prices throughout the United States. Three major insulin manufacturers – Eli Lilly, Novo Nordisk, and Sanofi – are reducing their product prices, a monumental win for patients, healthcare professionals, and the long-term care industry. Eli Lilly is at the forefront of this change, while Novo Nordisk and Sanofi plan to introduce more affordable options later this year.
Read more at prweb.com